1. Home
  2. /
  3. Available
  4. /
  5. Preferred product characteristics for therapeutic vaccines to improve tuberculosis treatment outcomes

Preferred product characteristics for therapeutic vaccines to improve tuberculosis treatment outcomes

Description

The preferred product characteristics (PPC) for therapeutic TB vaccines described in this document are intended to provide guidance to scientists, funding agencies, public and private sector organizations developing such vaccine candidates. This document presents potential clinical end-points for ev idence generation and discusses key considerations about potential clinical development strategies

Project details

Country
Year
Target Group
Vaccine
Type of protection
Type of research
Partners involved

Resources

Contact

Joeri Buis

KNCV Team

Contact me for more information about this research

Click to copy link of this header Menu

Add A Knowledge Base Question !

You will receive an email when your question will be answered.

+ = Verify Human or Spambot ?